Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 33.08%262.73B | 6.17%197.43B | 3.68%57.93B | 1.69%48.2B | 6.82%50.58B | 15.25%40.73B | 14.14%185.96B | 2.20%55.87B | 11.59%47.4B | 22.91%47.35B |
| Cost of revenue | 29.30%221.38B | 4.82%171.21B | 0.94%49.18B | -2.55%41.21B | 7.97%44.55B | 16.77%36.27B | 14.86%163.34B | 2.55%48.73B | 11.96%42.29B | 24.08%41.26B |
| Gross profit | 57.72%41.35B | 15.89%26.22B | 22.34%8.75B | 36.74%6.99B | -0.99%6.03B | 4.18%4.46B | 9.17%22.62B | -0.17%7.15B | 8.61%5.11B | 15.46%6.09B |
| Operating expense | 19.37%18.31B | 8.07%15.34B | 8.25%4.21B | 2.39%3.68B | 13.28%3.69B | 8.84%3.77B | 8.05%14.2B | 6.99%3.89B | 5.18%3.59B | 7.36%3.25B |
| Operating profit | 111.79%23.04B | 29.05%10.88B | 39.17%4.53B | 117.89%3.31B | -17.37%2.34B | -15.51%692M | 11.13%8.43B | -7.55%3.26B | 17.65%1.52B | 26.43%2.83B |
| Net non-operating interest income (expenses) | -231.34%-222M | -15.52%-67M | -150.00%-30M | 38.89%-11M | 115.38%2M | -86.67%-28M | 32.56%-58M | -9.09%-12M | 30.77%-18M | 43.48%-13M |
| Non-operating interest income | 38.46%18M | 8.33%13M | -20.00%4M | 50.00%3M | 0.00%4M | 100.00%2M | 0.00%12M | 0.00%5M | 0.00%2M | 0.00%4M |
| Non-operating interest expense | 200.00%240M | 14.29%80M | 100.00%34M | -30.00%14M | -88.24%2M | 87.50%30M | -28.57%70M | 6.25%17M | -28.57%20M | -37.04%17M |
| Net investment income | -55.17%325M | -4.48%725M | 91.44%358M | -347.37%-47M | -38.07%109M | -19.10%305M | 53.33%759M | 3.89%187M | -83.76%19M | 225.93%176M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -32.70%992M | 167.51%1.47B | 139.15%672M | 35,300.00%708M | 53.06%551M | 142.24%281M | -98.59%2M | |||
| Income from associates and other participating interests | -7.53%135M | 146M | 142M | -32M | -5M | 41M | 0 | 0 | 0 | 0 |
| Special income (charges) | -880.43%-359M | -61.34%46M | -2,675.00%-103M | 533.33%13M | -42.86%4M | 18.92%132M | 695.00%119M | 106.67%4M | 82.35%-3M | 141.18%7M |
| Less:Restructuring and mergern&acquisition | --241M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | -48.30%-218M | -27.83%-147M | --2M | -533.33%-13M | 42.86%-4M | -18.92%-132M | -675.00%-115M | --0 | -82.35%3M | -141.18%-7M |
| Less:Write off | 232.67%336M | 2,625.00%101M | ---- | ---- | ---- | ---- | ---4M | ---- | ---- | ---- |
| Other non-operating income (expenses) | -18.18%54M | 112.90%66M | 183.33%17M | -150.00%-3M | 247.62%31M | 50.00%6M | 96.55%-1M | 20M | ||
| Income before tax | 80.61%23.96B | 34.97%13.27B | 50.19%5.59B | 162.43%3.99B | -22.49%2.55B | -12.25%1.14B | 18.26%9.83B | -0.80%3.72B | 2.70%1.52B | 41.87%3.29B |
| Income tax | 55.63%6.45B | 29.63%4.15B | 51.16%1.62B | 126.71%1.29B | -21.15%876M | -19.51%359M | 24.38%3.2B | 4.07%1.07B | 11.57%569M | 45.23%1.11B |
| Net income | 91.95%17.51B | 37.55%9.12B | 49.83%3.97B | 183.40%2.7B | -23.18%1.67B | -8.34%780M | 15.54%6.63B | -2.61%2.65B | -1.86%952M | 40.13%2.18B |
| Net income continuous operations | 91.96%17.51B | 37.55%9.12B | 49.79%3.97B | 183.81%2.7B | -23.18%1.67B | -8.45%780M | 15.52%6.63B | -2.65%2.65B | -1.96%951M | 40.22%2.18B |
| Noncontrolling interests | 93.94%64M | 725.00%33M | -114.29%-3M | -100.00%-6M | 525.00%17M | 350.00%25M | 110.53%4M | 2,000.00%21M | 75.00%-3M | 80.00%-4M |
| Net income attributable to the company | 91.96%17.44B | 37.14%9.09B | 51.20%3.97B | 183.44%2.7B | -24.14%1.66B | -12.41%755M | 14.68%6.63B | -3.38%2.63B | -2.85%954M | 38.52%2.18B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 91.96%17.44B | 37.14%9.09B | 51.20%3.97B | 183.44%2.7B | -24.14%1.66B | -12.41%755M | 14.68%6.63B | -3.38%2.63B | -2.85%954M | 38.52%2.18B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 91.81%135.6067 | 37.03%70.7 | 51.08%30.8967 | 183.30%21.04 | -24.20%12.885 | -12.50%5.8783 | 14.58%51.5933 | -3.48%20.45 | -2.92%7.4267 | 38.46%16.9983 |
| Diluted earnings per share | 91.81%135.6067 | 37.03%70.7 | 51.08%30.8967 | 183.21%21.0334 | -24.20%12.885 | -12.50%5.8783 | 14.58%51.5933 | -3.46%20.45 | -2.92%7.4267 | 38.46%16.9983 |
| Dividend per share | 115.89%54.3333 | 67.78%25.1667 | 113.33%16 | 0 | 22.22%9.1667 | 0 | 0.00%15 | 0.00%7.5 | 0 | 0.00%7.5 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |